ETS1 and non-small cell lung carcinoma: A previous study has revealed that the transcription factor E26 transformation-specific-1 (ETS1) could affect disease progression in patients with non-small-cell lung cancer by up-regulating expression of miR-29b in the immune-evasion disease subtype [9].